These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31714357)

  • 61. Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana.
    Powis K; Lockman S; Smeaton L; Hughes MD; Fawzi W; Ogwu A; Moyo S; van Widenfelt E; von Oettingen J; Makhema J; Essex M; Shapiro RL
    Pediatr Infect Dis J; 2014 Nov; 33(11):1141-7. PubMed ID: 25037041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV Exposure and Formula Feeding Predict Under-2 Mortality in HIV-Uninfected Children, Botswana.
    Ajibola G; Leidner J; Mayondi GK; van Widenfelt E; Madidimalo T; Petlo C; Moyo S; Mmalane M; Williams PL; Cassidy AR; Shapiro R; Kammerer B; Lockman S
    J Pediatr; 2018 Dec; 203():68-75.e2. PubMed ID: 30318370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected.
    Barrios-Tascon A; Strehlau R; Patel F; Burke M; Shiau S; Shen Y; Arpadi SM; Abrams EJ; Tiemessen CT; Kuhn L;
    J Pediatr; 2024 Jul; 270():114018. PubMed ID: 38508485
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa.
    Naicker N; Yende-Zuma N; Kharsany ABM; Shozi H; Nkosi D; Naidoo A; Garrett N; Abdool Karim SS
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):596. PubMed ID: 35883114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
    Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
    Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014.
    Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
    Mussi-Pinhata MM; Freimanis L; Yamamoto AY; Korelitz J; Pinto JA; Cruz ML; Losso MH; Read JS;
    Pediatrics; 2007 Mar; 119(3):e694-704. PubMed ID: 17296782
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods.
    Duri K; Gumbo FZ; Munjoma PT; Chandiwana P; Mhandire K; Ziruma A; Macpherson A; Rusakaniko S; Gomo E; Misselwitz B; Mazengera LR;
    BMC Infect Dis; 2020 Oct; 20(1):725. PubMed ID: 33008316
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants: Results From the HPTN 040/PACTG 1043 Trial.
    Yeganeh N; Watts DH; Xu J; Kerin T; Joao EC; Pilotto JH; Theron G; Gray G; Santos B; Fonseca R; Kreitchmann R; Pinto J; Mussi-Pinhata MM; Veloso V; Camarca M; Mofenson L; Moye J; Nielsen-Saines K
    Pediatr Infect Dis J; 2018 Dec; 37(12):1271-1278. PubMed ID: 29750766
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uptake of care and treatment amongst a national cohort of HIV positive infants diagnosed at primary care level, South Africa.
    Mathivha E; Olorunju S; Jackson D; Dinh TH; du Plessis N; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):790. PubMed ID: 31526376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers.
    Desmonde S; Goetghebuer T; Thorne C; Leroy V
    Curr Opin HIV AIDS; 2016 Sep; 11(5):465-476. PubMed ID: 27716731
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
    Santosa WB; Staines-Urias E; Tshivuila-Matala COO; Norris SA; Hemelaar J
    AIDS; 2019 Aug; 33(10):1623-1633. PubMed ID: 30932959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    Herce ME; Chagomerana MB; Zalla LC; Carbone NB; Chi BH; Eliya MT; Phiri S; Topp SM; Kim MH; Wroe EB; Chilangwa C; Chinkonde J; Mofolo IA; Hosseinipour MC; Edwards JK
    PLoS Med; 2021 Sep; 18(9):e1003780. PubMed ID: 34534213
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of Feeding Practices and Growth of Urbanized African Infants Aged 6-12 Months Old by Maternal HIV Status in Gauteng Province, South Africa.
    Tshiambara P; Hoffman M; Legodi H; Botha T; Mulol H; Pisa P; Feucht U
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986230
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).
    Dadabhai S; Gadama L; Chamanga R; Kawalazira R; Katumbi C; Makanani B; Dula D; Hua N; Lau B; Mallewa M; Taha TE
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):7-14. PubMed ID: 30272628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.